Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight (TRIUMPH program)
Mistake 3: reducing the dose when side effects occur instead of holding steady When nausea or other GI symptoms appear after a dose increase, some researchers immediately drop back to the previous dose
If less than 48 hours remain, skip the missed dose and administer the next dose on the regularly scheduled day
The ADA guideline does state: "Combination of two GLP-1 receptor agonist-based therapies is not recommended due to lack of evidence and potential for additive adverse effects" [7]
Weight loss program participants gain access to lifestyle resources, education and referrals and benefit from discounted nutrition and personal training services
